Clinical Research Directory
Browse clinical research sites, groups, and studies.
Retrospective Study of Romiplostim for Platelet Engraftment After Allo-HSCT
Sponsor: Tongji Hospital
Summary
This is a retrospective observational study evaluating the efficacy and safety of romiplostim for promoting platelet engraftment in patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) at Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology between January 2025 to May 2026. Medical records were reviewed to collect data on platelet recovery time, transfusion requirements, and adverse events. The primary endpoint was time to platelet engraftment. Secondary endpoints included platelet recovery kinetics, transfusion requirements, transplant-related complications, and safety outcomes.No interventions were assigned as part of this study.
Official title: Retrospective Clinical Study on the Efficacy and Safety of Romiplostim for Promoting Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
103
Start Date
2025-01-01
Completion Date
2026-07-15
Last Updated
2026-08-05
Healthy Volunteers
No
Conditions
Locations (1)
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China